0001724521-24-000065.txt : 20240315
0001724521-24-000065.hdr.sgml : 20240315
20240315163016
ACCESSION NUMBER: 0001724521-24-000065
CONFORMED SUBMISSION TYPE: 144
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20240315
DATE AS OF CHANGE: 20240315
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Arcus Biosciences, Inc.
CENTRAL INDEX KEY: 0001724521
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 473898435
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 144
SEC ACT: 1933 Act
SEC FILE NUMBER: 001-38419
FILM NUMBER: 24755264
BUSINESS ADDRESS:
STREET 1: 3928 POINT EDEN WAY
CITY: HAYWARD
STATE: CA
ZIP: 94545
BUSINESS PHONE: (510) 694-6200
MAIL ADDRESS:
STREET 1: 3928 POINT EDEN WAY
CITY: HAYWARD
STATE: CA
ZIP: 94545
REPORTING-OWNER:
COMPANY DATA:
COMPANY CONFORMED NAME: Jarrett Jennifer
CENTRAL INDEX KEY: 0001671311
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 144
MAIL ADDRESS:
STREET 1: C/O MEDIVATION, INC.
STREET 2: 525 MARKET ST., 36TH FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94105
144
1
primary_doc.xml
144
0001671311
XXXXXXXX
LIVE
0001724521
Arcus Biosciences, Inc.
001-38419
3928 Point Eden Way
Hayward
CA
94545
510-694-6200
Jennifer Jarrett
Officer
COMMON
E*TRADE FINANCIAL CORPORATION
3 EDISON DRIVE
ALPHARETTA
GA
3005
16000
296000
90864829
03/18/2024
NYSE
COMMON
03/15/2024
Vesting of restricted stock granted 1/19/2021
Arcus Biosciences, Inc.
N
25000
03/15/2024
Services rendered
N
E*TRADE FINANCIAL CORPORATION
3 EDISON DRIVE
ALPHARETTA
GA
30005
COMMON STOCK
12/18/2023
11250
199621
E*TRADE FINANCIAL CORPORATION
3 EDISON DRIVE
ALPHARETTA
GA
30005
COMMON STOCK
12/19/2023
11492
207916
JP MORGAN SECURITIES LLC
390 MADISON AVENUE
6TH FLOOR
NEW YORK
NY
10017
COMMON STOCK
12/22/2023
21521
382275
JP MORGAN SECURITIES LLC
390 MADISON AVENUE
6TH FLOOR
NEW YORK
NY
10017
COMMON STOCK
02/26/2024
24555
492887
JP MORGAN SECURITIES LLC
390 MADISON AVENUE
6TH FLOOR
NEW YORK
NY
10017
COMMON STOCK
02/27/2024
34070
685215
The reported transactions represent mandatory sell-to-cover transactions effected pursuant to the Issuer's equity administration policy.
03/15/2024
01/15/2021
/s/ Jennifer Jarrett